Marine Boucaud - Axa Equitable Director
| EQH Stock | USD 35.64 0.01 0.03% |
Director
Ms. Marine de Boucaud is Senior Executive Director and Chief Human Resources Officer of AXA Equitable Life., subsidiary of the company. She is responsible for developing and executing a businessaligned human capital management strategy focused on leadership development, talent management and total rewards for AXA Equitable Life. Ms. de Boucaud also oversees internal communications and the AXA Foundation. Ms. de Boucaud was the Senior Executive Director and Chief Human Resources Officer of AXA Equitable Life since 2016. Previously, Ms. de Boucaud served as the Head of Human Resources of AXA France from October 2012 to June 2016
| Age | 48 |
| Address | 1345 Avenue Of The Americas, New York, NY, United States, 10105 |
| Phone | 212 554 1234 |
| Web | https://www.equitableholdings.com |
Axa Equitable Management Efficiency
The Axa Equitable's current Return On Tangible Assets is estimated to increase to 0.01. The Axa Equitable's current Return On Capital Employed is estimated to increase to 0. As of now, Axa Equitable's Total Current Assets are decreasing as compared to previous years. The Axa Equitable's current Return On Tangible Assets is estimated to increase to 0.01, while Net Tangible Assets are forecasted to increase to (2.9 B). Axa Equitable's management efficiency ratios could be used to measure how well Axa Equitable manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Christopher McCormick | Sun Life Financial | 61 | |
| James Cole | American International Group | 52 | |
| Helen Hicks | Sun Life Financial | 60 | |
| Diva Moriani | Assicurazioni Generali SpA | 49 | |
| Ines Mazzilli | Assicurazioni Generali SpA | 56 | |
| Arnold Steiner | Old Republic International | 83 | |
| Barbara Stymiest | Sun Life Financial | 64 | |
| Franco Urlini | Assicurazioni Generali SpA | 52 | |
| Simone Bemporad | Assicurazioni Generali SpA | N/A | |
| Jose Fernandes | BB Seguridade Participacoes | N/A | |
| John Fitzpatrick | American International Group | 63 | |
| Deanna Mulligan | Arch Capital Group | 51 | |
| Charles Kovaleskias | Old Republic International | N/A | |
| Patricia Audi | BB Seguridade Participacoes | 47 | |
| Flavio Cattaneo | Assicurazioni Generali SpA | 51 | |
| Thomas Motamed | American International Group | 72 | |
| Paola Sapienza | Assicurazioni Generali SpA | 52 | |
| Margaret Harris | Sun Life Financial | 63 | |
| Steven Bateman | Old Republic International | 62 | |
| Charles Kovaleski | Old Republic International | 72 | |
| Isabel Ramos | BB Seguridade Participacoes | 43 | |
Management Performance
| Return On Equity | 0.38 | ||||
| Return On Asset | 0.0023 |
Axa Equitable Holdings Leadership Team
Elected by the shareholders, the Axa Equitable's board of directors comprises two types of representatives: Axa Equitable inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axa. The board's role is to monitor Axa Equitable's management team and ensure that shareholders' interests are well served. Axa Equitable's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axa Equitable's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian Winikoff, Senior Executive Director and Head of U.S. Life, Retirement and Wealth Management of AXA Equitable Life | ||
| Jessica Baehr, Head Retirement | ||
| Robin Raju, Senior Executive Vice President, Chief Financial Officer | ||
| George Stansfield, Non-Executive Director | ||
| Marine Boucaud, Senior Executive Director and Chief Human Resources Officer of AXA Equitable Life | ||
| Gerald Harlin, Director | ||
| Connie Weaver, Chief Marketing Officer | ||
| Karima Silvent, Director | ||
| Bertram Scott, Independent Director | ||
| William Eckert, Chief Accounting Officer, Controller | ||
| Anders Malmstrom, Senior Executive Vice President and Chief Financial Officer | ||
| William IV, Chief VP | ||
| Kristi Matus, Independent Director | ||
| Erik CFA, Head Relations | ||
| Daniel Kaye, Independent Director | ||
| Thomas Buberl, Chairman of the Board | ||
| Seth Bernstein, Senior Executive Vice President and Head of Investment Management and Research | ||
| Jeffrey Hurd, Senior Executive Vice President and Chief Operating Officer | ||
| Bertrand PoupartLafarge, Director | ||
| Kevin Molloy, Head of Investor Relations | ||
| Nicholas Lane, Senior Executive Vice President and Head of U.S. Life, Retirement and Wealth Management of EQH and President of AXA Equitable Life Insurance Company | ||
| Joan LammTennant, Chairman of the Board | ||
| Isil Muderrisoglu, Head Relations | ||
| Michael Healy, Senior Executive Director and CIO of AXA Equitable Life | ||
| Constance Weaver, Chief Officer | ||
| Charles Stonehill, Independent Director | ||
| Francis Hondal, Independent Director | ||
| Adrienne Johnson, Senior Executive Director and Chief Transformation Officer of AXA Equitable Life | ||
| Ramon Oliveira, Independent Chairman of the Board | ||
| Nick Lane, Senior Executive Vice President and Head of U.S. Life, Retirement and Wealth Management of EQH and President of AXA Equitable Life Insurance Company | ||
| Jeffrey JD, Senior COO | ||
| Stephanie Withers, Chief Auditor | ||
| Dave Hattem, Senior Executive Vice President, Chief Legal Officer, Secretary | ||
| Josh Braverman, Senior Executive Director of AXA Equitable Life | ||
| Jose Gonzalez, Senior Executive Vice President, Chief Legal Officer, Company Secretary | ||
| Kermitt Brooks, Senior Executive Vice President | ||
| Mark Pearson, President, Chief Executive Officer, Director | ||
| Jose Esq, Chief EVP | ||
| Steven Joenk, Chief Officer |
Axa Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Axa Equitable a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.38 | ||||
| Return On Asset | 0.0023 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | (0.57) % | ||||
| Current Valuation | 12.81 B | ||||
| Shares Outstanding | 327.62 M | ||||
| Shares Owned By Insiders | 0.47 % | ||||
| Shares Owned By Institutions | 99.53 % | ||||
| Number Of Shares Shorted | 4.25 M | ||||
| Price To Earning | 3.79 X |
Pair Trading with Axa Equitable
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axa Equitable position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axa Equitable will appreciate offsetting losses from the drop in the long position's value.Moving together with Axa Stock
| 0.66 | ESGR | Enstar Group Limited | PairCorr |
| 0.86 | FIHL | Fidelis Insurance Report 28th of June 2024 | PairCorr |
| 0.88 | AIG | American International Financial Report 2nd of May 2024 | PairCorr |
Moving against Axa Stock
| 0.72 | AC | Associated Capital | PairCorr |
| 0.67 | GSHD | Goosehead Insurance Earnings Call This Week | PairCorr |
| 0.53 | DHIL | Diamond Hill Investment | PairCorr |
The ability to find closely correlated positions to Axa Equitable could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axa Equitable when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axa Equitable - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axa Equitable Holdings to buy it.
The correlation of Axa Equitable is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axa Equitable moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axa Equitable Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axa Equitable can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Axa Stock analysis
When running Axa Equitable's price analysis, check to measure Axa Equitable's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axa Equitable is operating at the current time. Most of Axa Equitable's value examination focuses on studying past and present price action to predict the probability of Axa Equitable's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axa Equitable's price. Additionally, you may evaluate how the addition of Axa Equitable to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Axa Equitable's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.961 | Dividend Share 0.88 | Earnings Share 3.48 | Revenue Per Share 30.037 | Quarterly Revenue Growth (0.01) |
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.